Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Cracking the code: learnings from oligonucleotide method development WATCH NOW

Video: APA 2015 – Reaching new heights in targeted quantitation with HRMS

15 Mar 2016
Written by Mark Wrona (Waters Corporation)
Chromatography MS (LC–MS/MS, HRMS, IMS)

https://www.youtube.com/watch?v=62i-2wAEAWgMark Wrona, Senior Science Manager at Waters Corporation, discusses the use of high resolution mass spectrometry (HRMS) for targeted quantitation studies. This presentation was originally given at APA 2015 in Boston (MA, USA).

Top content

  • The NAD dash: inside the molecule making longevity a measurable science
  • Sapient launches advanced FFPE Proteomics platform
  • Call for papers for Bioanalysis: Refreshing the immunogenicity testing paradigm

Related tags

HRMS microfluidics
Previous article

Related articles

7 JUL 2015 CHROMATOGRAPHY
Integration of microfluidic LC with HRMS for the analysis of analytes in biofluids: past, present and future (Waters)
2 OCT 2019 GENERAL INTEREST
Spotlight survey on HRMS in DMPK
10 JUL 2019 BIOMARKERS
A multiplex HRMS assay for quantifying selected human plasma bile acids as candidate OATP biomarkers
24 OCT 2011 CHROMATOGRAPHY
Assay dynamic range for DBS: battles on two fronts
17 OCT 2016 MS (LC–MS/MS, HRMS, IMS)
Quantitative HRMS in the age of Biologics – a commentary on the recent HRMS survey
7 MAR 2025 NEWS
Could lipidomic profiling guide personalized treatments for colorectal cancer?
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone